Role of oncogene activation during prenatal (transplacental) initiation and postnatal promotion of mouse skin tumours
Yamasaki, H.; Hollstein, M.; Cabral, J.R.; Tomatis, L.
Iarc Scientific Publications 96: 221-237
1989
ISSN/ISBN: 0300-5038 PMID: 2680947 Document Number: 338979
The transplacental initiation-postnatal promotion model of mouse skin carcinogenesis is useful in studying the molecular and cellular mechanisms of perinatal carcinogenesis. Offspring transplacentally exposed to an initiating dose of a carcinogen typically do not produce any skin tumours in the absence of postnatal treatment; many skin tumours appear only when they are treated with tumour-promoting agents postnatally. Tumour-promoting agents alone produce no skin tumours or only a few. Thus, two stages of carcinogenesis, initiation and promotion, can be conveniently separated. Our results indicate that fetal c-Ha-ras can be transplacentally activated through a specific point mutation by a carcinogen. However, since postnatal promotion was essential for the production of tumours, they also suggest that a cell harbouring such a mutation may remain dormant until it encounters a tumour-promoting stimulus. Since a higher fraction of carcinomas than papillomas contained the specific mutation in Ha-ras, it is postulated that those papillomas with the point mutation have a selective advantage to progress towards carcinomas.